arrow_back Back to App

Study on Remote Monitoring for Opioid Patients

This act mandates a study on the effects of remote monitoring for individuals prescribed opioids. The goal is to assess efficacy, patient outcomes, and potential cost savings, which could influence future healthcare policies and access to monitoring for citizens.
Key points
Mandates a study on remote monitoring for individuals prescribed opioids.
Assesses efficacy, patient outcomes, and potential cost savings of remote monitoring.
Examines current prevalence of monitoring, including in other countries.
Develops recommendations to improve availability and coverage of remote monitoring in healthcare programs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4093
Sponsor: Rep. Balderson, Troy [R-OH-12]
Process start date: 2023-06-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Remote Opioid Monitoring Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4093.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-14.

What are the main provisions?

Key points include:

  • Mandates a study on remote monitoring for individuals prescribed opioids.
  • Assesses efficacy, patient outcomes, and potential cost savings of remote monitoring.
  • Examines current prevalence of monitoring, including in other countries.
  • Develops recommendations to improve availability and coverage of remote monitoring in healthcare programs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Balderson, Troy [R-OH-12].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health